The Top 2 Nuclear Energy Stocks to Buy Right Now

Uranium spot prices recovered to $86.35 per pound by late April, with Citi seeing upside to $125, supporting stronger fundamentals for Cameco and BWX Technologies. Cameco has restarted mines and is expected to grow revenue and adjusted EBITDA at 8% and 12% CAGRs from 2025 to 2028, while BWX's backlog rose 50% year over year to $7.3 billion. Both companies appear well positioned to benefit from rising nuclear demand tied to decarbonization, AI, cloud, and data center growth.

Analysis

The key setup is not just higher uranium prices; it is a tighter, more strategic market where supply is becoming less elastic than demand. That favors the upstream miner in the near term, but the second-order winner is the integrated nuclear ecosystem: as utilities lock in fuel security, pricing power migrates from spot exposure toward long-cycle contracting, conversion/enrichment, and maintenance-heavy equipment. This is why the better risk-adjusted trade may be the more diversified nuclear platform rather than a pure commodity beta.

BWXT’s moat matters because it sits in the bottleneck segments that become harder to substitute as nuclear restarts broaden into SMRs, naval programs, and HALEU-linked supply chains. A backlog expansion of that magnitude typically matters more for visibility than for immediate EPS, because it de-risks forward revenue while giving the market a reason to pay up for duration. The hidden lever is capacity scarcity: if nuclear buildout accelerates, BWXT can benefit from pricing discipline well before unit volume fully inflects.

The main tail risk for both names is that enthusiasm outruns the pace of actual project execution. Uranium rallies can reverse sharply if utilities delay contracting, if new supply comes online faster than expected, or if policy support gets pushed into the right tail rather than the base case. For BWXT, the risk is more valuation than fundamental—if SMR adoption remains a 2027-2030 story, the current multiple already discounts a lot of optionality.

Consensus is probably underestimating how much of the near-term upside is already embedded in uranium miners versus how little is priced into the equipment and services layer. The more durable trade is not simply "long nuclear," but long the companies that monetize nuclear complexity and regulatory scarcity. That argues for owning the picks-and-shovels names on pullbacks and being selective on pure commodity exposure after sharp price spikes.

Key Decisions for Investors

• Overweight BWXT vs CCJ on a 6-12 month view: BWXT offers better earnings visibility and less direct commodity downside; use CCJ only as a tactical hedge on a continued uranium squeeze.
• Initiate a pair trade: long BWXT / short an industrials or defense ETF into strength, betting that nuclear scarcity carries a premium while broader cyclicals remain rate-sensitive over the next 3-6 months.
• If CCJ pulls back on any uranium spot-price consolidation, buy for a 2-4 quarter trade; use tight downside risk controls because the stock is likely to de-rate quickly if contracting momentum stalls.
• Sell upside calls on CCJ against a long position after sharp rallies to monetize volatility, since uranium sentiment can overshoot fundamentals and mean-revert on delay headlines.
• Hold off adding to BWXT only after multiple expansion from current levels unless backlog continues to accelerate; if execution stays intact, it remains the cleaner compounder over the next 1-2 years.